title: A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform.
abstract: Loss of insulin-producing β-cells is a central feature of diabetes. While a variety of potential replacement therapies are being explored, expansion of endogenous insulin-producing pancreatic islet β-cells remains an attractive strategy. β-cells have limited spontaneous regenerative activity; consequently, a crucial research effort is to develop a precise understanding of the molecular pathways that restrain β-cell growth and to identify drugs capable of overcoming these restraints. Herein an automated high-content image-based primary-cell screening method to identify β-cell replication-promoting small molecules is presented. Several, limitations of prior methodologies are surmounted. First, use of primary islet cells rather than an immortalized cell-line maximizes retention of in vivo growth restraints. Second, use of mixed-composition islet-cell cultures rather than a β-cell-line allows identification of both lineage-restricted and general growth stimulators. Third, the technique makes practical the use of primary islets, a limiting resource, through use of a 384-well format. Fourth, detrimental experimental variability associated with erratic islet culture quality is overcome through optimization of isolation, dispersion, plating and culture parameters. Fifth, the difficulties of accurately and consistently measuring the low basal replication rate of islet endocrine-cells are surmounted with optimized immunostaining parameters, automated data acquisition and data analysis; automation simultaneously enhances throughput and limits experimenter bias. Notable limitations of this assay are the use of dispersed islet cultures which disrupts islet architecture, the use of rodent rather than human islets and the inherent limitations of throughput and cost associated with the use of primary cells. Importantly, the strategy is easily adapted for human islet replication studies. This assay is well suited for investigating the mitogenic effect of substances on β-cells and the molecular mechanisms that regulate β-cell growth.
authors: Department of Medicine, Division of Endocrinology, Stanford University School of Medicine.
authors: Zhengshan
authors: Z
authors: Zhao
authors: Department of Medicine, Division of Endocrinology, Stanford University School of Medicine.
authors: Yassan
authors: Y
authors: Abdolazimi
authors: Department of Medicine, Division of Endocrinology, Stanford University School of Medicine.
authors: Neali A
authors: NA
authors: Armstrong
authors: Department of Medicine, Division of Endocrinology, Stanford University School of Medicine; jannes@stanford.edu.
authors: Justin P
authors: JP
authors: Annes
mesh_terms: D018929:Cell Culture Techniques; D002453:Cell Cycle; D002460:Cell Line; D006801:Humans; D050417:Insulin-Secreting Cells / Q000166:cytology*; D007515:Islets of Langerhans / Q000166:cytology*